CIK 0001636282 · Large accelerated filer
Spyre Therapeutics, Inc.
Sign in to watch- Ticker
- SYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464312787
- Phone
- 6176515940
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aeglea BioTherapeutics, Inc.
- 424B3 Offering Prospectus
- 8-K Event Material agreement · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Unregistered share sale
- UPLOAD Other SEC-generated Letter
- SC 13G/A Stake Amended Statement of Ownership
- S-1 Offering Registration Statement
- ARS Other Annual Report to Security Holders
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- DEF 14A Proxy Proxy Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- POS AM Other Post-effective Amendment for Registration Statement
- S-1/A Offering Registration Statement
Page 11 of 42 · 823 filings